Background {#Sec1}
==========

Primary thyroid lymphoma is a rare cause of malignancy, accounting for 2--5% of all thyroid malignancies \[[@CR1]\] and \< 2% of extranodal lymphomas \[[@CR2], [@CR3]\]. A rapidly enlarging mass was the most common clinical manifestations in earlier series, but recently small lesions are found at the early stage \[[@CR4]\]. It is a potentially lethal disease, but often responds well to appropriate treatments \[[@CR5]\]. Thyroid lymphoma is not always diagnosed easily, especially in its early phase, because most of the cases are associated with Hashimoto's thyroiditis.

Ultrasonography (US) of the thyroid is initially used for the diagnosis of thyroid lymphoma. On US, lymphoma is shown as hypoechoic lesions, but subacute thyroiditis, focal chronic thyroiditis, some thyroid cancers, and metastatic thyroid cancer is also shown as hypoechoic lesions mimicking thyroid lymphoma. Based on US findings of internal echo levels, borders, and posterior echoes, thyroid lymphoma can be classified as the nodular, diffuse, or mixed type \[[@CR6]\]. Although the nodular type often resembles follicular tumor or adenomatous nodule and the mixed type often resembles adenomatous goiter on US, these lesions can be often distinguished by an enhancement of posterior echoes. The diffuse type shows homogeneous and hypoechoic internal echoes, but these findings are also typical for severe chronic thyroiditis \[[@CR6], [@CR7]\].

Fine needle aspiration cytology (FNAC) is the next diagnostic strategy for thyroid lymphoma, but is challenging, particularly due to its histological similarities with mucosa-associated lymphoid tissue (MALT) lymphoma and chronic thyroiditis \[[@CR8], [@CR9]\]. The flow cytometry with CD45 gating on the FNAC specimen can be used to analyze the proportions of lymphocytic cells with κ and λ immunoglobulin light chains. The κ/λ deviation ratio of the light chain assessment is an important criterion for discriminating between polyclonal reactive processes such as chronic thyroiditis and monoclonal lymphomas. Strong deviation in the κ/λ ratio is regarded as suggestive monoclonal growth of lymphocytes, thus indicating thyroid lymphoma \[[@CR10]\].

Even with these modalities, a definite diagnosis is not established easily. A surgical interventions is often needed for the histopathological diagnosis, but it might be unnecessary for the benign lesions. This is especially true for the small or moderate-size lesions. Needle biopsy is usually useful for the diagnosis of diffuse large B-cell type lymphoma, but is often insufficient in the case of MALT lymphoma.

We have observed some hypoechoic lesions that were diagnosed as possible thyroid lymphoma based on the FNAC decrease in size or disappear during their clinical courses without definitive treatment. However, there is little information regarding the natural course of such hypoechoic lesions that were possible thyroid lymphoma based on FNAC findings. We conducted the present study to (*1*) clarify the natural course of hypoechoic thyroid lesions that were possible thyroid lymphoma, and (*2*) identify clinical features that might be used to discriminate benign non-progressive lesions from those with progressive character.

Methods {#Sec2}
=======

Between April 2012 and July 2016, 136 patients were suspected of having thyroid lymphoma on US examination at Kuma Hospital, where approximately 15,000 new patients with thyroid diseases are evaluated annually. US examinations were routinely performed by our well-experienced operators. US was performed using an APLIO 500 TUS-A500 system (Toshiba Medical Systems Co., Ltd., Otawara, Japan) with a PLT-805AT (Toshiba) or PLT-1005BT probe (Toshiba). Patients with systemic lymphoma or previously diagnosed lymphoma were excluded. Of these 136 patients, 122 were diagnosed as having probable or possible thyroid lymphoma by FNAC (Fig. [1](#Fig1){ref-type="fig"}). The remaining 14 patients were excluded from the study, because they had other diagnoses based on FNAC findings (eight specimens were normal or benign, one anaplastic carcinoma of the thyroid, one subacute thyroiditis or thyroid papillary carcinoma, and one metastatic renal cell carcinoma; the remaining three specimens were inadequate for diagnosis). Among the 122 patients, 57 were excluded from the study, because 56 were referred to other hospitals for the definitive diagnosis and chemo radiotherapy, and one patient dropped out from the follow-up study. Thus, the remaining 65 patients were investigated in this study. Forty-three patients strongly suspected of having thyroid lymphoma underwent thyroid surgery at our hospital for the definite diagnosis and 22 patients with comments of possible lymphoma on cytology were followed up with periodic US examination for 1--41 (median 11.5) months. Whether surgery or follow-up examination was determined by each doctor in charge based on clinical and radiological findings, including the rapidity of the enlargement of the thyroid mass, and the US and FNAC findings. Of 43 patients who underwent thyroid surgery at our hospital, 41 (95.3%) were diagnosed as definite thyroid lymphoma, and the other two (4.7%) were diagnosed as chronic thyroiditis (Fig. [1](#Fig1){ref-type="fig"}). Among the 41 patients who were diagnosed as definite thyroid lymphoma, 34 were diagnosed as MALT lymphoma and seven were diagnosed as diffuse large B-cell lymphoma. Whether the lesions of all 41 patients were limited to the thyroid was not known because all were referred to other hospitals to undergo further diagnostic examinations, including the determination of the disease stage, and treatment.Fig. 1Clinical flow and outcomes of patients with possible thyroid lymphoma based on US and FNAC

Hypoechoic lesions of the periodically followed-up 22 patients were analyzed. The US examination was repeated 1--3 month-interval at first and then 6 month-interval when no deterioration was observed. None of 22 patients were treated with steroids or immunosuppressive drugs during the follow-up examination. Other medications or supplementations, or dietary habit including iodine intake were not known in detail. When the maximum diameter of a hypoechoic lesion increased by ≥3 mm, we defined the case as an "increase" of the hypoechoic lesion. When the maximum diameter of a hypoechoic lesion reduced by ≥3 mm, we defined the case as a "decrease." When the hypoechoic lesions were not detected clearly at follow-up examination, it was defined as "disappeared." We established this parameter because, in our previous study, plus or minus 2 mm was recognized as an observation variation \[[@CR11]\]. In the present study, in some cases in which the entire thyroid volume was observed to have decreased, the maximum diameter of the hypoechoic lesions was measured and analyzed.

Representative US images showing "decrease" and "disappearance" are shown in Fig. [2](#Fig2){ref-type="fig"}. Our hospital uses its own ultrasound classification system for the diagnosis of thyroid nodules, which consists of five US classes (USC) based on the characteristics of thyroid nodules, such as a regular or irregular shape, solid or cystic content, the presence or absence of microcalcifications, extraglandal invasion, and other factors. The classification consists of five classes from 1 to 5. Intermediate classes from class 2 to class 4 (designated as classes 2.5 and 3.5) are also used (Table [1](#Tab1){ref-type="table"}) \[[@CR12]\]. Some cases of lymphoma with diffuse or mixed lesion are hardly classified according to USC, because this classification is mainly scored to thyroid nodules. However, in the present study, the US classification was applied to the hypoechoic lesions. The present study was approved by the Institutional Review Board of Kuma Hospital and the Ethics Committee in Kuma Hospital.Fig. 2Echograms of three representative patients whose hypoechoic lesions decreased or disappeared on careful follow-up examination. **a** A 74-year-old woman with a nodular hypoechoic lesion at presentation (A1) that had markedly decreased in size one month later (A2) (case No. 9 in Table [2](#Tab2){ref-type="table"}). **b** A 69-year-old woman with a severely hypoechoic lesion involving the both thyroid lobes (B1) that had almost disappeared 10 months later (B2), although the irregularity remained possibly due to underlying chronic thyroiditis (case No. 4 in Table [2](#Tab2){ref-type="table"}). **c** A 53-year-old woman with a diffuse severely hypoechoic lesion involving the whole thyroid (C1) that had markedly decreased in size 27 months later (C2) (case No. 1 in Table [2](#Tab2){ref-type="table"})Table 1Ultrasonographic classification for thyroid nodule at Kuma HospitalClassDescription1Round or anechoic lesion.2Regular-shaped nodule with cystic change. The echo level of solid lesion is similar to that of normal thyroid.3Solid and regular-shaped nodule. Internal echo is homogeneous, or may have strong echoes internally or at the capsule.4Solid and irregular-shaped nodule. Internal echo is usually low and may have fine strong echogenic spots.5Solid and irregular-shaped nodule with extrathyroid extension.Intermediate classes from class 2 to class 5 (designated as classes 2.5,3.5 and 4.5) are also used

The hypoechoic lesions in 22 patients who were followed up with periodic US examination decreased in size (*n* = 10), disappeared (*n* = 2), showed no change (*n* = 1) or increased in size (*n* = 3). The remaining six patients dropped out from the follow-up examination. Of the three patients whose hypoechoic lesions increased in size, one patient was referred to another hospital and diagnosed as diffuse large B-cell lymphoma; the other two patients were carefully followed up without further progression (Fig. [1](#Fig1){ref-type="fig"}).

Forty-one patients with histopathologically diagnosed thyroid lymphoma were defined as Group A, and 12 patients whose hypoechoic lesions decreased in diameter or disappeared as defined Group B (Fig. [1](#Fig1){ref-type="fig"}). Their clinical features, the diameter of hypoechoic lesions, US features at the first presentation, and the diagnostic categories of the Bethesda System for Reporting Thyroid Cytopathology (BethSys categories) were compared between Group A and B. Mann-Whitney *U*-test and chi-squared test (with Yate's continuity correction) were used to compare the two groups.

Results {#Sec3}
=======

Table [2](#Tab2){ref-type="table"} summarizes the clinical features of 16 patients who underwent follow-up US examinations of hypoechoic lesions that were diagnosed as possible thyroid lymphoma. Thyroid function tests at presentation showed hypothyroid (*n* = 1), subclinical hypothyroid (*n* = 4) and euthyroid (*n* = 11). Some patients were taking levothyroxine (LT4) before and during the follow-up examination. However, whether LT4 supplementation was involved in the decrease or disappearance of the hypoechoic lesions is unclear, because of the small number of the cases. All Group B patients were thyroglobulin antibody (TgAb)- and/or thyroid peroxidase antibody (TPOAb)-positive. As a result of FNAC, 'atypia of undetermined significance or follicular lesion of undetermined significance (AUS)' was diagnosed in eight, 'suspicious for 'malignancy' in two, 'malignancy' in one, and 'benign' in one patient. The pathological report of case 2 in Table [2](#Tab2){ref-type="table"} said that it was probably benign; however, lymphoma could not be completely excluded. On flow cytometry of the fine needle aspirations, the κ/λ ratio varied from 0.31 to 4.61. When κ/λ ratio was lower than 1.00, we converted κ/λ ratio to λ/κ ratio (deviation ratio) to discriminate between the polyclonal reactive process and the monoclonal reactive process that is characteristic to lymphomas.Table 2Clinical features of 16 patients who underwent follow-up US examinations of hypoechoic lesions that were diagnosed as possible thyroid lymphomaCaseAgeSexThyroid function^a^TgAb (IU/mL)TPOAb (IU/mL)Echo pattern of hypoechoic lesionsUS classBethSys^b^Duration of follow-up (months)Before (mm)After (mm)κ/λ deviation ratio^c^LT4 supplementation (μg/day)TSH during follow-upOutcome153Fsubclinical hypothyroid (with LT4 50 μg/day)4000≦535diffuse3AUS^d^2761471.2175normaldecrease262Fhypothyroid4000≦600≦diffuse3.5benign^e^30120801.50112.5suppresseddecrease366Feuthyroid2889nodular3.5AUS1225114.6150normaldecrease469Feuthyroid120.7600≦nodular3AUS1037disappearance3.14--normaldisappearance570Meuthyroid54118nodular3AUS3715121.84--normaldecrease671Msubclinical hypothyroid1171--nodular3malignancy637233.2050normaldecrease772Feuthyroid906--nodular2.5Suspicious for malignancy327142.9050normaldecrease874Feuthyroid512.9151nodular3AUS4112disappearance2.75--normaldisappearance974Feuthyroid688.816nodular3Suspicious for malignancy1105251.72--normaldecrease1074Feuthyroid121.8--nodular3AUS71692.0675suppresseddecrease1177Fsubclinical hypothyroid1402--diffuse3AUS2546401.5350normaldecrease1283Feuthyroid89.9--nodular3.5AUS623193.21--normaldecrease1366Feuthyroid235.5--nodular4AUS2222220.8675suppressedno change1446Feuthyroid609.6--nodular3Suspicious for malignancy72230----normalincrease1587Meuthyroid750.4≦16nodular3Suspicious for malignancy619234.09--normalincrease1694Fsubclinical hypothyroid586.326.5diffuse3Suspicious for malignancy11651601.8162.5normalincreaseThe normal range of TgAb is ≤39.9 U/mL; TPOAb: ≤27.9 U/mL. --: TPOAb not done or no levothyroxine (LT4) supplementationIntermediate US classes from class 2 to class 4 (designated as classes 2.5 and 3.5) are also used^a^Thyroid function at the first examination and diagnosis as possible thyroid lymphoma by FNAC^b^The Bethesda System for Reporting Thyroid Cytopathology^c^The κ/λ deviation ratio was calculated by λ/κ ratio when the κ/λ ratio was \< 1.00^d^Atypia of undetermined significance or follicular lesion of undetermined significance^e^Lymphoma cannot be denied

There were no significant differences in age, sex, thyroid function, TgAb, TPOAb, echo pattern of hypoechoic lesions, USC, BethSys, the diameter of hypoechoic lesions, κ/λ deviation ratio, LT4 supplementation or TSH between the patients whose hypoechoic lesions decreased in size or disappeared and patients whose lesions were unchanged or increased in size.

There were no significant differences in patient age, sex, or the diameter of the hypoechoic lesions between Groups A and B (Mann-Whitney *U*-test) (Table [3](#Tab3){ref-type="table"}). The USC and the κ/λ deviation ratio were significantly lower in Group B than Group A (*p* \< 0.001 and *p* \< 0.02, respectively). The USC of \< 3.5 \[9/12 (75.0%) in Group B; 10/41 patients (24.4%) in Group A\] was significantly more frequent (*p* \< 0.01), and the FNAC finding of 'benign' or 'AUS' \[9/12 (75.0%) in Group B; 12/41 patients (29.3%) in Group A\] was significantly more frequent (*p* \< 0.05) in Group B than Group A (Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}). Lastly, the κ/λ deviation ratio of the immunoglobulin (Ig) light chain in the FNAC specimens of \< 3.40 \[11/12 (91.7%) in Group B; 17/41 patients (41.5%) in Group A\] was significantly more frequent in Group B than Group A (*p* \< 0.01) (Table [6](#Tab6){ref-type="table"}).Table 3Comparison of clinical features of Group A and BGroup A (*n* = 41)Group B (*n* = 12)*p*-valueAge (year)67 (48--91)72 (53--83)0.35Sex (Male, number)1120.48Diameter of hypoechoic lesions (mm)35 (16--75)38 (12--120)0.51Group A is the patients with thyroid lymphoma diagnosed histopathologically following thyroid surgery. Group B is the patients whose hypoechoic lesions decreased or disappeared. Data are median and (ranges). The *p*-values were calculated by Mann-Whitney *U*-testTable 4Comparisons of US classification between the Group A (*n* = 41) and Group B (*n* = 12)US classGroup AGroup B2.5113983.5934210*P* \< 0.01Classes 2.5 and 3.5 designate intermediate classes between 2 &3 and 3 & 4, respectivelyTable 5Comparisons of the diagnostic categories of the Bethesda System for Reporting Thyroid Cytopathology between the Group A (n = 41) and Group B (n = 12)Diagnostic categoriesGroup AGroup BBenign11AUS118Suspicious for malignancy222Malignant71*P* \< 0.02*US*: ultrasound. *AUS*: atypia of undetermined significance or follicular lesion of undetermined significanceBenign: benign, but with the comment that lymphoma cannot be deniedTable 6Comparisons of Groups A and B regarding the κ/λ deviation ratio of Ig light chainκ/λ deviation ratioGroup AGroup BTotal≥3.4024125\< 3.40171128Total411253The κ/λ deviation ratio of \< 3.40 was significantly more frequent in Group B compared to Group A (*p* \< 0.01, chi-square test (with Yate's continuity correction)). When the κ/λ deviation ratio was lower than 1.00, we converted it to the λ/κ ratio (deviation ratio)

Discussion {#Sec4}
==========

The characteristics and natural course of hypoechoic lesions that were diagnosed as possible thyroid lymphoma based on the FNAC findings were investigated. Careful US examinations were repeatedly performed in 22 of 65 patients, and hypoechoic lesions decreased in diameter in 10 patients (10 of the 22; 45.5% or 10 of 65 patients; 15.4%), and disappeared in two patients (two of 22; 9.1% or two of 65 patients; 3.1%).

The USC and the κ/λ deviation ratio were significantly lower in Group B than Group A, and the FNAC finding of 'benign' or 'AUS' was significantly more frequent in Group B than Group A. Although thyroid lymphoma typically presents with a rapidly enlarging neck mass leading to compressive symptoms \[[@CR4]\], some hypoechoic lesions diagnosed as possible thyroid lymphoma might regress in their natural courses in the present study.

Several studies have demonstrated that *Helicobacter pylori* infection is associated with low-grade gastric MALT lymphoma, and that the eradication of *Helicobacter pylori* can cause histological regression of the lymphoma \[[@CR13], [@CR14]\]. Uohashi et al. reported that a hypoechoic lesion in the right lobe disappeared spontaneously after being diagnosed pathologically as non-Hodgkin's lymphoma following a contralateral lobe resection, and suggested spontaneous regression of acute inflammation \[[@CR15]\]. Okamoto et al. reported a patient whose primary thyroid lymphoma of cytotoxic T-cell origin regressed spontaneously \[[@CR16]\]. Although its cause remains unknown, it may be attributable to an association of acute inflammation \[[@CR17], [@CR18]\], and immune mechanisms such as those involving T-helper cells or natural killer cells of the peripheral blood \[[@CR19]\].

However, to our best knowledge, there has been no report that the natural course of hypoechoic lesions suspected of being possible thyroid lymphoma was studied extensively. With the combination of US, FNAC, and CD gating analysis for κ/λ deviation, candidate for the surgery could be accurately selected in 41 out of 43 patients (95%) as demonstrated in Group A. However, the management of not strongly suggestive of lymphoma may be controversial. In the present study, the hypoechoic lesion decreased in size in 10, and disappeared in two out of 22 patients, suggesting the careful observation for such lesions.

The limitation of the present study concerns the retrospective analysis that may eliminate the ability to obtain the strong conclusions. Selection of open surgery or careful observation depends on various factors including the results of FNAC and patients' previous courses. Therefore, the proper diagnostic rate of Group A was higher than in that of Group B, and the selection bias might cause the difference of the course of the two groups. The nature of the hypoechoic lesions that regressed during the follow-up examination is unclear in the present study, because open biopsies were not performed in these patients. Some could be actually low-grade thyroid lymphoma, but others could be focal or regional lymphocytic thyroiditis, atypical subacute thyroiditis, or other etiology-unknown lesion(s). Further prospective studies including histopathology and factor(s) involved in the regression or progression of the lesions are needed to investigate the true nature of such lesions, and to clarify the best method of managing such patients.

Hypoechoic lesions suspected of having possible lymphoma decreased in size or disappeared in 12 out of 22 patients (55%), and such a regression should be emphasized in the present study. Because most of these lesions cannot be diagnosed definitely by core needle biopsy, open surgery might be considered. But unnecessary surgeries for benign lesions might be avoided.

Conclusion {#Sec5}
==========

Our study suggests that some hypoechoic thyroid lesions that are possible thyroid lymphoma based on US and FNAC might decrease in size or disappear during the careful observation. A careful observation before surgery is suggested for those lesions such as USC \< 3.5, a κ/λ deviation ratio \< 3.4, and the FNAC classification of 'benign' or 'atypia of determined significance or follicular lesions of undetermined significance'. However, an open biopsy or thyroid surgery should be considered in case of the increasing lesion in diameter on follow-up US examination.

AUS

:   Atypia of undetermined significance or follicular lesion of undetermined significance

BethSys categories

:   Bethesda System for Reporting Thyroid Cytopathology

FNAC

:   Fine needle aspiration cytology
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MALT

:   Mucosa-associated lymphoid tissue
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:   Thyroglobulin antibody
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:   Thyroid peroxidase antibody
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:   Ultrasonography

USC

:   US classification
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